Official Website: Ripple Neuro

source confidence: Medium status: Useful updated 2026-06-19

Type
source
Status
Useful
Confidence
Medium
Source Type
official-page
URL
https://rippleneuro.com
Archive
https://web.archive.org/web/20260608022341/https://rippleneuro.com/
Archived
2026-06-08
Publisher
Ripple Neuro
Raw
raw/ripple-neuro-official-website/2026-08-11-aa09d54fdae2.txt
Retrieved
2026-08-12
Updated
2026-06-19

Summary

Ripple Neuro's official website describes a line of neural recording and stimulation systems for research neuroscience — the Grapevine processor family, the Trek portable wireless system, and the Summit closed-loop neuromodulation system. The site also references a clinical-leaning sister brand, Ripple Neuromed, at rippleneuromed.com.

Useful Claims

  • Ripple describes portable, wireless Trek processors and Grapevine front-end systems for simultaneous neural recording and stimulation.
  • The company says its ASICs were developed under DARPA, DoD, and SBIR funding.
  • This capture does not establish exact Grapevine channel counts, the company's founding history, NIH HEAL program work, or the scope of a Ripple Neuromed clinical arm.
  • Products are marketed to neuroscience research users (researchers, labs); consumer BCI is not mentioned on this capture.

Verbatim

"Record and stimulate on every channel. Developed under DARPA, DoD and SBIR funding, Ripple's proprietary ASICs offer exceptional signal quality and low noise in a compact package." — Home page, product heading

"Featuring on-board processing and wireless control, Ripple's flagship processor, the Trek, untethers you from conventional constraints of behavioral electrophysiology." — Home page, Trek section

"As a company founded and run by neuroscience researchers, Ripple is uniquely capable of helping you plan and grow your projects, as well as providing you with the best tools available for truly novel research." — Home page, contact section

Reliability Notes

Official company source. Strongest for product specifications, system architecture, and program areas. Channel counts, waveform quality, and stimulation artifact rejection claims should be cross-checked with published neuroscience literature citing Ripple systems. Ownership structure, funding details, and revenue are not disclosed on the website.

Capture gap. Specifications such as 512-channel Grapevine capacity, explicit University of Utah spinout history, operational since 2004, NIH HEAL listings, and Ripple Neuromed were recorded from earlier site material and are absent from this homepage capture.

Related Pages